Literature DB >> 1400379

Identification of a cis-acting element that enhances the pigment cell-specific expression of the human tyrosinase gene.

K Shibata1, Y Muraosa, Y Tomita, H Tagami, S Shibahara.   

Abstract

To identify the cis-acting element that is responsible for the pigment cell-specific expression of the human tyrosinase gene, we analyzed the promoter activity of its 5'-flanking region by transient expression assays. The fusion genes were constructed by inserting the 5'-flanking region of the human tyrosinase gene upstream from the firefly luciferase gene and were introduced into human melanoma cells and HeLa cells. We thus found the element, located between 2.7 and 1.8 kilobase pairs upstream from the transcription initiation site, that enhances the transient expression of the luciferase reporter gene in melanoma cells, but not in HeLa cells, the tyrosinase gene expression of which is not detectable. Using the fusion genes containing putative enhancer elements under the control of the heterologous simian virus 40 promoter, we identified the pigment cell-specific enhancer of approximately 200 base pairs (bp) between -2.0 and -1.8 kilobase pairs and localized the core sequence to a 39-bp region. This 39-bp core element was then confirmed to direct the melanoma cell-specific expression of the reporter gene under the tyrosinase gene promoter. We thus propose that this core element is responsible for the pigment cell-specific expression of the human tyrosinase gene.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1400379

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Analyses of loss-of-function mutations of the MITF gene suggest that haploinsufficiency is a cause of Waardenburg syndrome type 2A.

Authors:  Y Nobukuni; A Watanabe; K Takeda; H Skarka; M Tachibana
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

2.  Endoplasmic reticulum retention is a common defect associated with tyrosinase-negative albinism.

Authors:  R Halaban; S Svedine; E Cheng; Y Smicun; R Aron; D N Hebert
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

3.  CDF-1-mediated repression of cell cycle genes targets a specific subset of transactivators.

Authors:  J Zwicker; F C Lucibello; V Jérôme; S Brüsselbach; R Müller
Journal:  Nucleic Acids Res       Date:  1997-12-15       Impact factor: 16.971

4.  Exchange of viral promoter/enhancer elements with heterologous regulatory sequences generates targeted hybrid long terminal repeat vectors for gene therapy of melanoma.

Authors:  R M Diaz; T Eisen; I R Hart; R G Vile
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

5.  Melanocyte-specific expression of the human tyrosinase promoter: activation by the microphthalmia gene product and role of the initiator.

Authors:  N J Bentley; T Eisen; C R Goding
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

6.  WIPI1 coordinates melanogenic gene transcription and melanosome formation via TORC1 inhibition.

Authors:  Hsiang Ho; Rubina Kapadia; Sejad Al-Tahan; Safoora Ahmad; Anand K Ganesan
Journal:  J Biol Chem       Date:  2011-02-11       Impact factor: 5.157

7.  A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression.

Authors:  S Moffatt; N Tanaka; K Tada; M Nose; M Nakamura; O Muraoka; T Hirano; K Sugamura
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

8.  Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene.

Authors:  K Yasumoto; K Yokoyama; K Shibata; Y Tomita; S Shibahara
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

9.  Brachyury-related transcription factor Tbx2 and repression of the melanocyte-specific TRP-1 promoter.

Authors:  S Carreira; T J Dexter; U Yavuzer; D J Easty; C R Goding
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

Review 10.  Cellular genetic tools to control oncolytic adenoviruses for virotherapy of cancer.

Authors:  Dirk M Nettelbeck
Journal:  J Mol Med (Berl)       Date:  2007-12-19       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.